Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis

Posted on Posted in AMRC Research

Date: 06 Mar 2017

 

Kawasaki disease (KD) is a systemic vasculitis and childhood febrile disease that can lead to cardiovascular complications. The diagnosis of KD depends on its clinical features, and thus it is sometimes difficult to make a definitive diagnosis. In order to identify diagnostic serum biomarkers for KD, we explored serum KD-related proteins, which differentially expressed during the acute and recovery phases of two patients by mass spectrometry (MS). We identified a total of 1,879 proteins by MS-based proteomic analysis. The levels of three of these proteins, namely lipopolysaccharide-binding protein (LBP), leucine-rich alpha-2-glycoprotein (LRG1), and angiotensinogen (AGT), were higher in acute phase patients. In contrast, the level of retinol-binding protein 4 (RBP4) was decreased. To confirm the usefulness of these proteins as biomarkers, we analyzed a total of 270 samples, including those collected from 55 patients with acute phase KD, by using western blot analysis and microarray enzyme-linked immunosorbent assays (ELISAs). Over the course of this experiment, we determined that the expression level of these proteins changes specifically in the acute phase of KD, rather than the recovery phase of KD or other febrile illness. Thus, LRG1 could be used as biomarkers to facilitate KD diagnosis based on clinical features.

 

Link to full article

 

For inquiries regarding this press release

Yayoi KIMURA

E-mail: ykimura@yokohama-cu.ac.jp   Phone: +81 45 787 2519

Proteome Research Center,
Yokohama City University Advanced Medical Research Center

Fukuura 3-9, Kanazawa-ku, Yokohama, 236-0004 JAPAN